Clinical Trial

Assessment of the GORE® EXCLUDER® Conformable AAA Endoprosthesis in the Treatment of Abdominal Aortic Aneurysms

Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
The purpose of the study is to assess the safety and effectiveness of the GORE® EXCLUDER® Conformable AAA Endoprosthesis to treat an infrarenal aneurysm located in the abdominal aorta. Performance of the GORE® EXCLUDER® Conformable AAA Endoprosthesis will be judged by separate performance goals.
Protocol Amendment History 16 amendments
This ClinicalTrials.gov record has been amended 16 times since 2015-06-30; most recent amendment 2025-08-11.
Status change: Recruiting → Active, Not Recruiting 2023-01-26
Status change: Not Yet Recruiting → Recruiting 2018-01-19
Trial Details
NCT Number NCT02489539
Lead Sponsor W.L.Gore & Associates
Conditions Aortic Aneurysm, Abdominal
Enrollment 175 participants
Start Date 2017-12-19
Primary Completion 2023-05-25 (estimated)
Study Completion 2027-12-31 (estimated)
Updated on ClinicalTrials.gov 2025-08-13